NASDAQ:VRPX   Virpax Pharmaceuticals, Inc.
One more COVID idea, could just grab some commons and wait to see if there is any merit to their Antiviral nasal spray. In on some commons at $4.40, will wait a few weeks to see if this catches any strength
Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.